Joseph A. Sparano, MD, on Stage II–III Breast Cancer and CTCs

2017 San Antonio Breast Cancer Symposium
Tweet this page

Joseph A. Sparano, MD, of Montefiore Medical Center/Albert Einstein College of Medicine, discusses findings that suggest circulating tumor cells 5 years after diagnosis are prognostic for late recurrence in operable stage II–III breast cancer (Abstract GS6-03).

Advertisement

Advertisement

Advertisement